Human Recombinant Noggin, STEMCELL Technologies (CAT#: STEM-CT-0934-ZJF)

Noggin binds to and antagonizes bone morphogenetic protein (BMP) ligands of the transforming growth factor beta (TGF-β) family. Noggin supports maintenance of undifferentiated human embryonic stem cells in vitro, and can be used to prevent spontaneous differentiation in the short term (Chaturvedi et al.). Noggin is essential for development of structures derived from ectoderm embryonic somite, skeletal patterning, and neurogenesis in vivo. It also influences chondrogenesis, osteogenesis, and joint formation (Krause et al.), and promotes dopaminergic differentiation of embryonic stem cells and subsequent survival of dopamine neurons (Chiba et al.).

Subtype: Cytokines
Cell Type: Neural Cells, PSC-Derived, Neurons, Pluripotent Stem Cells
Species: Human
Area of Interest: Neuroscience, Stem Cell Biology
Purity: ≥ 95%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human/Mouse Recombinant NT-3, STEMCELL Technologies
Human Recombinant NT-4, STEMCELL Technologies
Human Recombinant Oncostatin M, STEMCELL Technologies
Human Recombinant Oncostatin M, ACF, STEMCELL Technologies